Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bubley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|January 21, 2023
Tacrine-Based Hybrids: Past, Present, and FutureAnna Bubley, Alexaner Erofeev, Peter Gorelkin, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 9, 2024
On the optical response of novel coumarin-fused NIR BODIPY dyes to X-raysNikita Lifanovsky, Daniil Spector, Anton Egorov, et al.
ACS Applied Bio Materials|May 2, 2024
Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark ToxicityDaniil Spector, Anna Bubley, Anastasia Zharova, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Photoactivatable Cisplatin-Combretastatin-BODIPY Pt(IV) Prodrug for Dual-Action Light-Controlled ChemotherapyDaniil V Spector, Georgy Karetnikov, Anna Bubley, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|January 21, 2023
Tacrine-Based Hybrids: Past, Present, and FutureAnna Bubley, Alexaner Erofeev, Peter Gorelkin, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 9, 2024
On the optical response of novel coumarin-fused NIR BODIPY dyes to X-raysNikita Lifanovsky, Daniil Spector, Anton Egorov, et al.
ACS Applied Bio Materials|May 2, 2024
Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark ToxicityDaniil Spector, Anna Bubley, Anastasia Zharova, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Photoactivatable Cisplatin-Combretastatin-BODIPY Pt(IV) Prodrug for Dual-Action Light-Controlled ChemotherapyDaniil V Spector, Georgy Karetnikov, Anna Bubley, et al.
Pageof 1